1. Relating pre-treatment non-Gaussian intravoxel incoherent motion diffusion-weighted imaging to human papillomavirus status and response in oropharyngeal carcinoma.
- Author
-
Sijtsema ND, Lauwers I, Verduijn GM, Hoogeman MS, Poot DHJ, Hernandez-Tamames JA, van der Lugt A, Capala ME, and Petit SF
- Abstract
Background and Purpose: Diffusion-weighted imaging (DWI) is a promising technique for response assessment in head-and-neck cancer. Recently, we optimized Non-Gaussian Intravoxel Incoherent Motion Imaging (NG-IVIM), an extension of the conventional apparent diffusion coefficient ( ADC ) model, for the head and neck. In the current study, we describe the first application in a group of patients with human papillomavirus (HPV)-positive and HPV-negative oropharyngeal squamous cell carcinoma. The aim of this study was to relate ADC and NG-IVIM DWI parameters to HPV status and clinical treatment response., Materials and Methods: Thirty-six patients (18 HPV-positive, 18 HPV-negative) were prospectively included. Presence of progressive disease was scored within one year. The mean pre-treatment ADC and NG-IVIM parameters in the gross tumor volume were compared between HPV-positive and HPV-negative patients. In HPV-negative patients, ADC and NG-IVIM parameters were compared between patients with and without progressive disease., Results: ADC , the NG-IVIM diffusion coefficient D , and perfusion fraction f were significantly higher, while pseudo-diffusion coefficient D* and kurtosis K were significantly lower in the HPV-negative compared to HPV-positive patients. In the HPV-negative group, a significantly lower D was found for patients with progressive disease compared to complete responders. No relation with ADC was observed., Conclusion: The results of our single-center study suggest that ADC is related to HPV status, but not an independent response predictor. The NG-IVIM parameter D, however, was independently associated to response in the HPV-negative group. Noteworthy in the opposite direction as previously thought based on ADC ., Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: This work was funded by a research grant from Elekta AB (Stockholm, Sweden) and a research grant from The Dutch Cancer Society (KWF 2019-12141). Erasmus MC Cancer Institute also has a research collaboration with Accuray Inc (Sunnyvale, CA, USA) and Varian, a Siemens Healthineers Company (Palo Alto, CA, USA)., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF